. Cartoon representations of the crystal structures of A) EcDHFR (PDB 1RX 24 ) and B) TmDHFR (PBD 1D1G 21 ), with bound ligands (MTX = methotrexate) shown as sticks, and C) the DHFR-catalysed reduction of dihydrofolate and folate to form tetrahydrofolate. Figure 1  109x145mm (300 x 300 DPI) Figure 2 . A) Arrhenius plots for hydride (circles) and deuteride (triangles) transfer from NADPH/D to H2F (red) 44 and folate (blue) catalysed by TmDHFR under single-turnover conditions at pH 7, B) plots of the KIE on a logarithmic abscissa against the inverse temperature at pH 7 for H2F (red) 44 and folate (blue), and C) pH dependence of the hydride transfer rate constant at 25 ºC for H2F (red) 55 and folate (blue). . Key regions of the 1 H NMR spectra of folate (black), H2F (blue), NADPH (green) and a mixture of NADP+ and H4F (red) (A), and of 1 H NMR spectra acquired during reduction of folate using NADPH in the presence of TmDHFR (B) and EcDHFR (C), and using in situ generated NADPD in the presence of TmDHFR (D). In B and D, the sharp singlet at ~3.6 ppm is a 13 C satellite from the buffer resonance. The region from 3.25 to 3.65 ppm, which contains the H4F H6, H7 and H9 resonances, is shown at 4x magnification in panels B-D. Figure 3 55x18mm (300 x 300 DPI) Figure 4 . 1 H-13 C HSQC spectra of the H6/H7/H9 region of tetrahydrofolate produced using TmDHFR with folate and NADPH (blue), EcDHFR with dihydrofolate and NADPD (red), and TmDHFR with folate and NADPD (black). The 1H projection shown is for tetrahydrofolate produced using NADPH, with assignments taken references 32 and 33. The sharp singlet at ~3.6 ppm in the projection is a 13 C satellite from the buffer resonance, coincident with the H7S resonance, and is not responsible for the observed cross-peak. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57 58 59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57 58 59 Figure 6 . Kinetic scheme for the EcDHFR-catalysed reduction of folate, adapted from references 1 (all values except on/off and hydride transfer rate constants for folate) and 31 (folate on/off rate constants). E represents enzyme (DHFR), NH represents NADPH, N + represents NADP + , and F represents folate. The preferred catalytic cycle in the presence of saturating folate and NADPH is highlighted in red. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  2 ABSTRACT. Mammalian dihydrofolate reductases (DHFR) catalyse the reduction of folate more efficiently than the equivalent bacterial enzymes, despite typically having similar efficiencies for the reduction of their natural substrate dihydrofolate. In contrast, we show here that DHFR from the hyperthermophilic bacterium Thermotoga maritima is able to catalyse reduction of folate to tetrahydrofolate with a similar efficiency to reduction of dihydrofolate under saturating conditions. NMR and mass spectrometry experiments showed no evidence for production of free dihydrofolate during either the EcDHFR-or TmDHFR-catalysed reductions of folate, suggesting that both enzymes perform the two reduction steps without release of the partially reduced substrate. Our results imply that the reaction proceeds more efficiently in 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 3 Dihydrofolate reductase (DHFR) is an essential enzyme in many organisms; it catalyses the NADPH-dependent reduction of 7,8-dihydrofolate (H 2 F) to 5,6,7,8-tetrahydrofolate (H 4 F).
Tetrahydrofolate is required for many one-carbon transfer reactions, most notably in the production of purines, deoxythymidine, glycine, methionine and (in prokaryotes) pantothenic acid. As such DHFR is an important drug target and is a clinical target for antibacterial, antimalarial and anticancer therapies. Almost all known chromosomal DHFRs are monomeric enzymes; the structure, dynamics and kinetics of the prototypic enzyme from E. coli (EcDHFR) ( Figure 1A ) have been extensively studied. 1-20 However, DHFR from the hyperthermophilic bacterium Thermotoga maritima (TmDHFR) forms an extremely stable homodimer 21,22 ( Figure   1B ) with lower catalytic efficiency than monomeric DHFRs. 23, 24 Dimerisation is important for the high thermostability of TmDHFR, but in itself dimerisation is not responsible for the lower catalytic activity of TmDHFR compared to monomeric DHFRs. [25] [26] [27] Instead, the more open nature of the active site renders the active site less protected from solvent which leads to the reduction in catalytic activity. 21, [25] [26] [27] [28] Page 9 of 34 Biochemistry   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 Interestingly, vertebrate DHFRs can reduce folate in addition to their natural substrate dihydrofolate. 29 This allows the more stable folate to be used in the supplementation of foods to reduce the incidence of neural tube defects. 30 Bacterial DHFRs, on the other hand, typically do not reduce folate efficiently. 29 The folate specificity of EcDHFR can be increased by introducing loop regions from chicken DHFR. 31 In X-ray single crystal structures of DHFR, folate and dihydrofolate bind almost identically to the enzyme. 4 Therefore, both molecules present the Re-face of the pterin at C6 as the most likely Page 10 of 34 Biochemistry   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 5 candidate for attack by the C4 pro-R hydride of NADPH ( Figure 1B ). NMR studies with DHFR from Lactobacillus casei (LcDHFR) indeed showed that when folate is fully reduced, both transferred hydrides are present on the same face of the product tetrahydrofolate. 32, 33 Because initial reduction at C7 would require both an unfavourable hydride transfer geometry and protonation at the solvent-inaccessible N8, it has been suggested that the initial product of folate reduction is 5,6-dihydrofolate, rather than the natural substrate 7,8-dihydrofolate, and that 5,6dihydrofolate rearranges to form the more stable 7,8-dihydrofolate, presumably without leaving the active site of the enzyme, prior to the second reduction step. [34] [35] [36] This is supported by neutron diffraction studies, which suggest that N5 of folate is protonated in the EcDHFR.NADP + .folate complex. 37 It has been noted, however, that this does not solve the problem of N8 protonation, 34, 36 which is still required for the rearrangement of 5,6-dihydrofolate to 7,8dihydrofolate, and that such apparently unavoidable difficulties in the chemistry are the likely cause of the lower rates of folate reduction compared to dihydrofolate reduction. Here, however, we show that in contrast to other bacterial DHFRs, TmDHFR catalyses reduction of folate with similar efficiency to reduction of dihydrofolate.
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MATERIALS AND METHODS
Chemicals. NADPH, NADP + and isopropyl-β-D-thiogalactopyranoside (IPTG) were purchased from Melford. Folate and 2 H 8 -isopropanol were purchased from Sigma. 7,8dihydrofolate was prepared by dithionite reduction of folate. 38 EcDHFR, 39, 40 TmDHFR, 24,26 NADPD 39 and TbADH 39 were prepared as described previously. Reactant concentrations were determined spectrophotometrically using extinction coefficients of 6,200 cm -1 M -1 at 339 nm for NADPH and NADPD, and 28,000 cm -1 M -1 at 282 nm for folate and dihydrofolate. 41 NMR experiments. All NMR experiments were performed at 37 ºC on a Bruker AVANCE III 600 MHz ( 1 H) spectrometer with a QCI-P cryoprobe. Spectra were acquired in 100 mM Page 12 of 34 Biochemistry   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 7 potassium phosphate buffer (pH 7.0) containing 1 mM NaCl and 10% D 2 O, using excitation sculpting for solvent suppression (pulse programme zgesgp). Reference spectra were acquired for NADPH, NADP + , folate and dihydrofolate. A reference spectrum of a mixture of tetrahydrofolate and NADP + was acquired following incubation of dihydrofolate and NADPH with EcDHFR for five minutes.
ACS Paragon Plus Environment
The TmDHFR-catalysed reaction was monitored by mixing folate (2.5 mM), NADPH (5 mM, 2 eq.) and TmDHFR (125 µM, 0.05 eq.) in the NMR tube. For the EcDHFR-catalysed reaction 10 mM folate, 20 mM NADPH and 1 mM (0.1 eq.) EcDHFR were used. Solvent-suppressed 1D 1 H spectra (zgesgp) were recorded until no significant change in resonance intensity was observed, and a 1 H-13 C HSQC spectrum was then recorded. The reaction catalysed by TmDHFR was performed in 50 mM Tris buffer (pH 7.0) containing 1 mM NaCl and 10% D 2 O.
The high salt content of our NADPD led to low-quality NMR spectra. Therefore, to determine the hydride transfer face, a coupled enzyme assay was used to generate NADPD in situ. Folate (2.5 mM), TmDHFR (125 µM, 0.05 eq.), TbADH (1 mg of freeze-dried enzyme 39 ) and 2 H 8isopropanol (25 µL, ~570 µM, 0.23 eq.; also used to provide the lock signal) were mixed in 50 mM Tris buffer (pH 7.0) containing 1 mM NaCl (500 µL final volume). Higher volumes of 2 H 8isopropanol caused precipitation over time, which led to poor NMR spectra. The reaction was initiated by addition of NADP + (250 µM, 0.1 eq.) and solvent-suppressed 1D 1 H spectra (zgesgp) and 1 H-13 C HSQC spectra were recorded over 3 hours. Reference 1 H and 1 H-13 C HSQC spectra of 6-2 H-tetrahydrofolate were acquired using this coupled assay with dihydrofolate and EcDHFR instead of folate and TmDHFR.
LC-MS analysis. The reaction was also monitored by LC-MS using a Waters Synapt G2-Si time-of-flight mass spectrometer coupled to a Waters Acquity UPLC system with an Acquity Page 13 of 34 Biochemistry   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 8 C18 reverse phase column held at 40 ºC throughout the run. Reactions were performed by mixing folate (50 µM), NADPH (100 µM) and TmDHFR (2.5 µM, 0.05 eq.) or EcDHFR (5 µM, 0.1 eq.) in 50 mM Tris buffer, pH 7.0, containing 1 mM NaCl and 10 mM β-mercaptoethanol.
Reactions were allowed to proceed to ~50% completion (as determined by UV at 340 nm) before removal of the enzyme using a 12 kDa cut-off filter and injection of 1 µL of the filtrate onto the column. UV spectroscopy showed that folate, dihydrofolate and tetrahydrofolate concentrations were not affected by the filtration step. Compounds were eluted using a gradient of 5-95% aqueous acetonitrile (containing 0.1% formic acid) over 10 minutes, and mass spectra were acquired scanning over m/z 100-1000 in ESP+Ve mode. The reactions and analysis were performed in duplicate. All processing was performed using MassLynx 4. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 10 observed with NADPH as cofactor were compared with those observed with NADPD. At all temperatures, the KIE with folate as substrate was not significantly different to that observed previously with dihydrofolate 44 (Figure 2 and Tables S1-S3 ). Furthermore, the apparent pK a for the reaction with folate was 5.77 ± 0.03, similar to the value of 5.83 ± 0.06 observed with dihydrofolate 25 (Figure 2 and Table S4 ). In EcDHFR, the pH dependence of the single-turnover rate constant is determined by the pK a of protonated dihydrofolate within the active site of the enzyme (6.5), which is elevated substantially from its solution value. 45 Although the pK a of protonated dihydrofolate within the active site of TmDHFR has not been experimentally verified, the pH dependence of the TmDHFR-catalysed reaction is likely also to be determined by this value. We have previously suggested that the lower apparent pK a for the TmDHFR-catalysed reaction is due to the more open, 21 and therefore solvent-accessible, active site, which prevents such extensive modulation of the substrate pK a . 28 As both proposed mechanisms require N8 protonation before the second reduction event, the similar pK a values for the reactions with folate and dihydrofolate suggest that TmDHFR is able to modulate the pK a at N8 of folate quite efficiently. It may be that the more solvent-accessible active site in TmDHFR actually facilitates N8 protonation, by providing solvent-mediated routes to protonation and cation stabilisation not available in DHFRs with more tightly closed active sites. A number of crystallographic water molecules are seen in the folate-binding site of TmDHFR in complex with NADP + and methotrexate (PDB 1D1G), including some buried within the active site pocket. 21 Given the low flexibility and paucity of histidine residues in TmDHFR, 21 a pH dependent conformational change, as seen for apo-EcDHFR, 46 seems less likely.
Page 16 of 34 Biochemistry   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 11 Figure 2 . A) Arrhenius plots for hydride (circles) and deuteride (triangles) transfer from NADPH/D to H 2 F (red) 44 and folate (blue) catalysed by TmDHFR under single-turnover conditions at pH 7, B) plots of the KIE on a logarithmic abscissa against the inverse temperature at pH 7 for H 2 F (red) 44 and folate (blue), and C) pH dependence of the hydride transfer rate constant at 25 ºC for H 2 F (red) 55 and folate (blue). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 12 It was not possible to obtain a value for k H from single-turnover kinetic data with EcDHFR.
Although a small loss of fluorescence was observed over short timescales, with rate constant 571.5 ± 43.0 s -1 at 20 ºC, a kinetic isotope effect of 1 was observed, demonstrating that the event causing this loss of fluorescence was not the chemical step of the catalytic cycle. A subsequent increase in fluorescence at longer timescales meant that k H could not be determined.
NMR experiments. NMR experiments were performed to confirm that EcDHFR and TmDHFR convert folate to tetrahydrofolate and to determine whether any free dihydrofolate is produced.
EcDHFR-catalysed reduction of dihydrofolate led to loss of the strong singlet resonances for the two H7 and the two H9, and appearance of four new multiplets for H6, H7 R , H7 S and the two H9 of tetrahydrofolate as expected 32, 33 ( Figure 3A) . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 13 Incubation of folate and NADPH in the presence of 0.05 equivalents of TmDHFR led to loss of resonances corresponding to these compounds and growth of resonances corresponding to tetrahydrofolate and NADP + (Figure 3B ), confirming that tetrahydrofolate was formed by the TmDHFR-catalysed reduction of folate. For EcDHFR, four-fold higher concentrations of folate and NADPH and 0.1 equivalents of the enzyme were required before useful results could be obtained. Tetrahydrofolate and NADP + resonances were visible after a few hours, although the folate and NADPH resonances were not greatly diminished ( Figure 3C ), as expected from the poor efficiency of EcDHFR-catalysed folate reduction. Additional time led to a further decrease in the folate and NADPH resonance intensity and an increase in the NADP + resonance intensity, although the tetrahydrofolate resonance intensity did not increase further and spectral quality was diminished, presumably due to oxidation of the tetrahydrofolate. For both enzymes, the decrease in integral for NADPH and folate loss, and the increase in integral for NADP + , are proportional to one another ( Figures 3B and 3C) . As NADPH and folate are present in a 2:1 ratio, this shows that they are depleted in a 2:1 ratio as expected.
No resonances corresponding to dihydrofolate were observed for either enzyme at any time during the experiment (Figure 3 ). As the reactions were performed with saturating concentrations of NADPH and folate, then if dihydrofolate were released from the enzyme during the catalytic cycle, the high folate concentration would favor folate binding over dihydrofolate re-binding, and consequently more rapid reduction of folate than dihydrofolate. This in turn would lead to a build-up of dihydrofolate. When a 1:1 mixture of folate and dihydrofolate was used, both enzymes preferentially catalysed reduction of dihydrofolate ( Figure S2 ), as expected from our kinetics results. However, the dihydrofolate released from the enzyme is unlikely to successfully 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 14 compete with the saturating folate for the active site under the experimental conditions. The NMR experiments therefore strongly suggest that dihydrofolate is not released from the active site of the enzyme.
To determine on which face of folate the two hydride transfers take place, a coupled enzyme assay was used to generate NADPD in situ. TmDHFR was incubated with folate in the presence of NADP + , 2 H 8 -isopropanol and alcohol dehydrogenase from Thermoanaerobacter brockii (TbADH). Based on our previous work with TmDHFR in organic co-solvents, isopropanol is not expected to have a significant impact on TmDHFR catalysis at the concentrations used, 47 although reaction rates were reduced due to the KIE on the reaction (vide supra), leading to poorer tetrahydrofolate signals. As observed previously for LcDHFR, 32,33 signals corresponding to H6 and H7 S were not seen in the 1 H NMR spectrum or the 1 H-13 C HSQC of the tetrahydrofolate product ( Figure 3D and Figure 4 ), confirming that hydride transfer to both sites on folate occurred on the same face.
Page 20 of 34 Biochemistry   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57 TmDHFR with folate and NADPD (black). The 1 H projection shown is for tetrahydrofolate produced using NADPH, with assignments taken references 32 and 33. The sharp singlet at ~3.6 ppm in the projection is a 13 C satellite from the buffer resonance, coincident with the H 7 S resonance, and is not responsible for the observed cross-peak.
LC-MS analysis. LC-MS was used to provide further evidence for tetrahydrofolate production without formation of free dihydrofolate. Following incubation of folate and NADPH with TmDHFR and EcDHFR, peaks corresponding to NADP + and tetrahydrofolate could clearly be observed, although retention times were a little variable between runs ( Figure 5, Figures S3-S6 ).
Extracted ion chromatograms revealed no evidence of dihydrofolate ( Figures S7-S9 ). However, repetition of the LC-MS analysis following addition of dihydrofolate showed that this compound could be easily detected by our system (Figure 5C and Figures S7-S9 ). The sensitivity of LC-MS compared to NMR confirms that no free dihydrofolate is produced during the reduction of folate by either enzyme. As, like the NMR experiments above, these reactions were performed with saturating concentrations of NADPH and folate, this demonstrates that dihydrofolate is not released from the active site of the enzyme. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57 Supplementary Information (Figures S3-S9 ).
Reduction of folate by EcDHFR and TmDHFR.
For both enzymes, no free dihydrofolate was observed during the reaction. This strongly suggests that dihydrofolate is not released from the active site of either enzyme, but that the catalytic cycle continues via release of NADP + to form the DHFR:H 2 F binary complex followed by re-binding of NADPH to form the DHFR:NADPH:H 2 F Michaelis complex. This is to be expected for EcDHFR from published kinetic data ( Figure 6) 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 maritima are not known, TmDHFR has a higher affinity for the reactants than EcDHFR, making it more likely that the NADPH concentration will be saturating. In addition, the rate constants for binding events in TmDHFR will be even higher than those of release events. The data obtained here also suggest that, as seen for EcDHFR, 1,31 the rate constants for product release from the TmDHFR:NADP + :H 2 F and TmDHFR:NADP + :H 4 F complexes are substantially smaller than those for NADP + release. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 18 There are a number of possible explanations for the greater rate of folate reduction by TmDHFR compared to EcDHFR. If the initial reduction occurs at C6, then TmDHFR must be better able to catalyse the rearrangement of 5,6-dihydrofolate to 7,8-dihydrofolate (by N5 deprotonation, 1,2-hydride shift from C6 to C7, and N8 protonation) prior to the second reduction. As both reduction steps show a substantial primary KIE on NADPH oxidation, this rearrangement must be fast compared to the hydride transfer events. Alternatively, if the initial reduction occurs at C7, then TmDHFR must be better able to support the arrangement of reactants required for this, and/or better able to support protonation at N8. The common feature is protonation of N8. As discussed above, the similarity in the apparent pK a values for the two reduction steps suggests that TmDHFR is able to modulate the pK a at N8 of folate quite efficiently. It may therefore be that, with its less solvent-accessible active site, EcDHFR fails to modulate the pK a of folate so efficiently, and rates of folate reduction will be greater at lower pH.
Unfortunately, as we were unable to measure a rate constant for EcDHFR-catalysed hydride transfer to folate, we cannot test this.
CONCLUSIONS
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